CSF beta-endorphin levels in patients with infantile autism. 1997

S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan.

We measured CSF levels of beta-endorphin, an opioid hormone, in 19 patients with infantile autism and in 3 patients with Rett syndrome, and compared them with control values. In infantile autism, CSF levels of beta-endorphin did not differ significantly from those of age-matched controls. There was no significant correlation between CSF levels and clinical symptoms, including self-injurious behavior, pain insensitivity, and stereotyped movement. However, CSF levels of beta-endorphin were significantly higher in the patients with Rett syndrome than in the control (p < .05). Data suggest that neurons containing beta-endorphin may not be involved in patients with infantile autism. Thus, there is no relationship between dysfunction of brain opioid and autism.

UI MeSH Term Description Entries
D008297 Male Males
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001321 Autistic Disorder A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V) Autism, Infantile,Kanner's Syndrome,Autism,Autism, Early Infantile,Disorder, Autistic,Disorders, Autistic,Early Infantile Autism,Infantile Autism,Infantile Autism, Early,Kanner Syndrome,Kanners Syndrome
D001615 beta-Endorphin A 31-amino acid peptide that is the C-terminal fragment of BETA-LIPOTROPIN. It acts on OPIOID RECEPTORS and is an analgesic. Its first four amino acids at the N-terminal are identical to the tetrapeptide sequence of METHIONINE ENKEPHALIN and LEUCINE ENKEPHALIN. Endorphin, beta,beta-Endorphin (1-31),beta Endorphin
D013239 Stereotyped Behavior Relatively invariant mode of behavior elicited or determined by a particular situation; may be verbal, postural, or expressive. Behavior, Stereotyped,Behaviors, Stereotyped,Stereotyped Behaviors
D015518 Rett Syndrome An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199) Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome,Cerebroatrophic Hyperammonemia,Autism, Dementia, Ataxia, and Loss of Purposeful Hand Use,Rett Disorder,Rett's Disorder,Rett's Syndrome,Autism Dementia Ataxia Loss of Purposeful Hand Use Syndrome,Cerebroatrophic Hyperammonemias,Hyperammonemia, Cerebroatrophic,Hyperammonemias, Cerebroatrophic,Retts Syndrome,Syndrome, Rett,Syndrome, Rett's
D016555 Matched-Pair Analysis A type of analysis in which subjects in a study group and a comparison group are made comparable with respect to extraneous factors by individually pairing study subjects with the comparison group subjects (e.g., age-matched controls). Analysis, Matched-Pair,Paired Comparisons,Analyses, Matched-Pair,Analysis, Matched Pair,Comparison, Paired,Comparisons, Paired,Matched Pair Analysis,Matched-Pair Analyses,Paired Comparison

Related Publications

S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
January 1987, Pediatric neurology,
S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
January 1993, The Kurume medical journal,
S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
August 1987, Life sciences,
S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
July 1988, Journal of the American Academy of Child and Adolescent Psychiatry,
S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
September 1984, Neurological research,
S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
May 1983, Masui. The Japanese journal of anesthesiology,
S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
March 1988, Revista espanola de fisiologia,
S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
January 1985, Archivos de neurobiologia,
S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
January 1985, Peptides,
S Nagamitsu, and T Matsuishi, and T Kisa, and H Komori, and M Miyazaki, and T Hashimoto, and Y Yamashita, and E Ohtaki, and H Kato
January 1993, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!